AeRang Kim MD PhD

Pediatric Hematology & Oncology•Washington, DC

Pediatric Sarcoma Oncology, Pediatric Solid Tumor Oncology

Associate Professor, Pediatrics, George Washington University School of Medicine and Health Sciences

Join to View Full Profile

111 Michigan Avenue NorthwestWashington, DC 20010
Phone+1 202-476-2800
Fax+1 202-476-5685

Education & Training

Johns Hopkins Bloomberg School of Public HealthPhD, 2005 - 2009
Johns Hopkins UniversityFellowship, Pediatric Hematology/Oncology, 2004 - 2008
NYU Grossman School of MedicineResidency, Pediatrics, 2001 - 2004
University of Illinois College of MedicineClass of 2001

Certifications & Licensure

DC State Medical License 2010 - 2026
MD State Medical License 2005 - 2026
VA State Medical License 2022 - 2026
NY State Medical License 2003 - 2005
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Clinical Trials

Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy Start of enrollment: 2001 Nov 01
Completed
Phase 1
Sorafenib Tosylate in Treating Younger Patients With Relapsed or Refractory Rhabdomyosarcoma, Wilms Tumor, Liver Cancer, or Thyroid Cancer Start of enrollment: 2012 Jan 01
Completed
Phase 2
SARC023: Ganetespib and Sirolimus in Patients With MPNST (Malignant Peripheral Nerve Sheath Tumors) Start of enrollment: 2013 Dec 01
Completed
Phase 1, Phase 2
MR-guided High Intensity Focused Ultrasound (HIFU) on Pediatric Solid Tumors
COMPLETED
PHASE1
A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors Start of enrollment: 2016 Oct 01
Terminated
Phase 1
A Study of Ramucirumab (LY3009806) in Children With Refractory Solid Tumors Start of enrollment: 2015 Dec 11
Completed
Phase 1
A Study of Olaratumab (LY3012207) in Participants With Advanced Soft Tissue Sarcoma Start of enrollment: 2016 Mar 01
Completed
Phase 1, Phase 2
Pevonedistat, Azacitidine, Fludarabine Phosphate, and Cytarabine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Start of enrollment: 2019 May 17
Completed
Phase 1
CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Desmoplastic Small Round Cell Tumor Start of enrollment: 2020 Jan 22
ACTIVE_NOT_RECRUITING
PHASE1, PHASE2
CAMPFIRE: A Study of Ramucirumab (LY3009806) in Children and Young Adults With Synovial Sarcoma Start of enrollment: 2020 Mar 04
Terminated
Phase 1, Phase 2
Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors Start of enrollment: 2019 Jan 28
RECRUITING
Roles: Contact
Vincristine and Temozolomide in Combination With PEN-866 for Adolescents and Young Adults With Relapsed or Refractory Solid Tumors Start of enrollment: 2024 Oct 31
RECRUITING
PHASE1, PHASE2
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

3 citations
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma.
Paul A Meyers, Noah Federman, Najat Daw, Peter M Anderson, Lara E Davis
Journal of Clinical Oncology. 2024-11-01
Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics.
R Taylor Sundby, Jeffrey J Szymanski, Alexander C Pan, Paul A Jones, Sana Z Mahmood
Clinical Cancer Research. 2024-10-01
1 citations
Phase II study of vemurafenib in children and young adults with tumors harboring BRAF V600 mutations: NCI-COG pediatric MATCH trial (APEC1621) Arm G.
Marie V Nelson, AeRang Kim, P Mickey Williams, Sinchita Roy-Chowdhuri, David R Patton
The Oncologist. 2024-08-05

Press Mentions

Children’s National Hospital Becomes First Pediatric Hospital Designated a Center of Excellence by Focused Ultrasound FoundationSeptember 24th, 2020
A Melanoma Drug Shows Promise for NF1 PlexiformsSeptember 30th, 2019
MedCityNews – Pediatric Device Innovators Forum Explores State of Focused UltrasoundJuly 15th, 2021